Skip to content

Physical Activity for a Long and Healthy Life

Physical Activity for a Long and Healthy Life - Project FINE

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01430143
Acronym
FINE
Enrollment
64
Registered
2011-09-07
Start date
2009-09-30
Completion date
2011-06-30
Last updated
2018-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2, Insulin Resistance, Overweight

Keywords

Exercise

Brief summary

The aim of the study is to 1) delineate the molecular mechanisms behind the large variation in insulin sensitivity among apparently healthy subjects and to 2) establish the dose-response relationship between physical training and a) metabolic health, b) appetite and c) cultural health.

Interventions

BEHAVIORALExercise

Daily exercise for 12 weeks.

Sponsors

Universitetssenteret på Kjeller
CollaboratorOTHER
Center for Healthy Aging
CollaboratorUNKNOWN
The Novo Nordic Foundation
CollaboratorOTHER
Copenhagen University Hospital, Denmark
CollaboratorOTHER
Glostrup University Hospital, Copenhagen
CollaboratorOTHER
University of Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy according to interview * Caucasian * Sedentary, Vo2max \< 45 ml/kg/min * BMI 25-30 kg/m2 * Fat percentage 25% \< * Weight stable (+/- 2 kg within past 6 months)

Exclusion criteria

* First degree relatives with type 2 diabetes * Hemoglobin concentration \< 8 mmol/l * Fasting plasma glucose 6.1 mmol/l \< * Blood pressure 140/90 mmHg \< * Regular intake of medicine

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in insulin sensitivity at 12 weeksAt baseline and 12 weeksAs measured by a hyperinsulinemic, isoglycemic clamp combined with skeletal muscle and adipose tissue biopsies as well as low-dose PET/CT.

Secondary

MeasureTime frameDescription
Change from baseline in body composition af 2, 6 and 12 weeksAt baseline, 2, 6 and 12 weeksAs measured by DEXA- and MRI-scanning.
Change from baseline in appetite at 12 weeksAt baseline and 12 weeksAs measured by food records, controlled diets, meal tests and appetite hormones
Motivational factors for exerciseDuring and for up to 1½ year after the interventionEthnographic field work
Diameter of t-tubuli in skeletal muscleAt baselineAs measured in skeletal muscle biopsies by electron and confocal microscopy

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026